Accelerate Diagnostics, Inc
AXDXDelisted Jul 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000727207
Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Accelerate Diagnostics, Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 46 | 47 | +1 |
| Shares | 4.81M | 4.72M | −89.4K (−1.9%) |
| Value | $8.20M | $5.69M | −$2.51M (−30.7%) |
New holders (8)
Institutions that held Accelerate Diagnostics, Inc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 29,652 | $35.6K | 0.00% |
| Jane Street Group, LLC | 22,415 | $26.9K | 0.00% |
| Two Sigma Securities, LLC | 16,936 | $20.3K | 0.00% |
| Virtu Financial LLC | 11,214 | $13.0K | 0.00% |
| Citigroup Inc | 10,678 | $12.8K | 0.00% |
| Stratos Wealth Partners, LTD. | 10,628 | $12.8K | 0.00% |
| BNP Paribas Arbitrage, SA | 357 | $428 | 0.00% |
| MAI Capital Management | 36 | $44 | 0.00% |
Sold out (7)
Institutions that held Accelerate Diagnostics, Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 19,866 | $34.0K |
| Assetmark, Inc | 710 | $1.21K |
| Householder Group Estate & Retirement Specialist, LLC | 1,155 | $1.00K |
| Barclays PLC | 100 | $171 |
| Providence Capital Advisors, LLC | 4 | $7 |
| Advisor Group Holdings, Inc. | 3 | $5 |
| Occudo Quantitative Strategies LP | 11,225 | – |